139 related articles for article (PubMed ID: 38736632)
1. Oral ribose supplementation in dystroglycanopathy: A single case study.
Thewissen RMJ; Post MA; Maas DM; Veizaj R; Wagenaar I; Alsady M; Kools J; Bouman K; Zweers H; Meregalli PG; van der Kooi AJ; van Doorn PA; Groothuis JT; Lefeber DJ; Voermans NC
JIMD Rep; 2024 May; 65(3):171-181. PubMed ID: 38736632
[TBL] [Abstract][Full Text] [Related]
2. ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice.
Cataldi MP; Blaeser A; Lu P; Leroy V; Lu QL
Mol Ther Methods Clin Dev; 2020 Jun; 17():271-280. PubMed ID: 31988979
[TBL] [Abstract][Full Text] [Related]
3. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan.
Gerin I; Ury B; Breloy I; Bouchet-Seraphin C; Bolsée J; Halbout M; Graff J; Vertommen D; Muccioli GG; Seta N; Cuisset JM; Dabaj I; Quijano-Roy S; Grahn A; Van Schaftingen E; Bommer GT
Nat Commun; 2016 May; 7():11534. PubMed ID: 27194101
[TBL] [Abstract][Full Text] [Related]
4. Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy.
Kanagawa M; Toda T
J Neuromuscul Dis; 2017; 4(4):259-267. PubMed ID: 29081423
[TBL] [Abstract][Full Text] [Related]
5. Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-l-Ribitol Pyrophosphorylase A Muscular Dystrophy.
van Tol W; van Scherpenzeel M; Alsady M; Riemersma M; Hermans E; Kragt E; Tasca G; Kamsteeg EJ; Pennings M; van Beusekom E; Vermeulen JR; van Bokhoven H; Voermans NC; Willemsen MA; Ashikov A; Lefeber DJ
Clin Chem; 2019 Oct; 65(10):1295-1306. PubMed ID: 31375477
[TBL] [Abstract][Full Text] [Related]
6. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.
Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC
Elife; 2021 Jan; 10():. PubMed ID: 33513091
[TBL] [Abstract][Full Text] [Related]
7. CDP-glycerol inhibits the synthesis of the functional
Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy.
Kuwabara N; Imae R; Manya H; Tanaka T; Mizuno M; Tsumoto H; Kanagawa M; Kobayashi K; Toda T; Senda T; Endo T; Kato R
Nat Commun; 2020 Jan; 11(1):303. PubMed ID: 31949166
[TBL] [Abstract][Full Text] [Related]
9. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy.
Kanagawa M; Kobayashi K; Tajiri M; Manya H; Kuga A; Yamaguchi Y; Akasaka-Manya K; Furukawa JI; Mizuno M; Kawakami H; Shinohara Y; Wada Y; Endo T; Toda T
Cell Rep; 2016 Mar; 14(9):2209-2223. PubMed ID: 26923585
[TBL] [Abstract][Full Text] [Related]
11. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals.
Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T
J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954
[TBL] [Abstract][Full Text] [Related]
12. Cell endogenous activities of fukutin and FKRP coexist with the ribitol xylosyltransferase, TMEM5.
Nishihara R; Kobayashi K; Imae R; Tsumoto H; Manya H; Mizuno M; Kanagawa M; Endo T; Toda T
Biochem Biophys Res Commun; 2018 Mar; 497(4):1025-1030. PubMed ID: 29477842
[TBL] [Abstract][Full Text] [Related]
13. Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2I.
Cataldi MP; Vannoy CH; Blaeser A; Tucker JD; Leroy V; Rawls R; Killilee J; Holbrook MC; Lu QL
Mol Ther; 2023 Dec; 31(12):3478-3489. PubMed ID: 37919902
[TBL] [Abstract][Full Text] [Related]
14. CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model.
Tokuoka H; Imae R; Nakashima H; Manya H; Masuda C; Hoshino S; Kobayashi K; Lefeber DJ; Matsumoto R; Okada T; Endo T; Kanagawa M; Toda T
Nat Commun; 2022 Apr; 13(1):1847. PubMed ID: 35422047
[TBL] [Abstract][Full Text] [Related]
15. FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients.
Awano H; Saito Y; Shimizu M; Sekiguchi K; Niijima S; Matsuo M; Maegaki Y; Izumi I; Kikuchi C; Ishibashi M; Okazaki T; Komaki H; Iijima K; Nishino I
J Clin Neurosci; 2021 Oct; 92():215-221. PubMed ID: 34509255
[TBL] [Abstract][Full Text] [Related]
16. Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.
Cataldi MP; Lu P; Blaeser A; Lu QL
Nat Commun; 2018 Aug; 9(1):3448. PubMed ID: 30150693
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review.
Taniguchi-Ikeda M; Morioka I; Iijima K; Toda T
Mol Aspects Med; 2016 Oct; 51():115-24. PubMed ID: 27421908
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.
Gicquel E; Maizonnier N; Foltz SJ; Martin WJ; Bourg N; Svinartchouk F; Charton K; Beedle AM; Richard I
Hum Mol Genet; 2017 May; 26(10):1952-1965. PubMed ID: 28334834
[TBL] [Abstract][Full Text] [Related]
19. Compound Heterozygous
Gaertner A; Burr L; Klauke B; Brodehl A; Laser KT; Klingel K; Tiesmeier J; Schulz U; Knyphausen EZ; Gummert J; Milting H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743126
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
